A systematic review of biomarkers for disease progression in Alzheimer's disease.
<h4>Background</h4>Using surrogate biomarkers for disease progression as endpoints in neuroprotective clinical trials may help differentiate symptomatic effects of potential neuroprotective agents from true slowing of the neurodegenerative process. A systematic review was undertaken to d...
Guardado en:
Autores principales: | David J M McGhee, Craig W Ritchie, Paul A Thompson, David E Wright, John P Zajicek, Carl E Counsell |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ff5c14770f064f16b884a63baec52225 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biomarkers in Alzheimer’s disease
por: Janeiro Manuel H., et al.
Publicado: (2020) -
Transfer Learning for Alzheimer’s Disease through Neuroimaging Biomarkers: A Systematic Review
por: Deevyankar Agarwal, et al.
Publicado: (2021) -
Alzheimer's disease: Newer biomarkers
por: Ankit Dangi, et al.
Publicado: (2021) -
Salivary Biomarkers in Alzheimer´s Disease
por: Santos,Gustavo A. A, et al.
Publicado: (2020) -
High degree of heterogeneity in Alzheimer's disease progression patterns.
por: Natalia L Komarova, et al.
Publicado: (2011)